Literature DB >> 25521772

Emotion episodes during psychotherapy sessions among women newly diagnosed with gynecological cancers.

Shannon Myers Virtue1, Sharon L Manne1, Kathleen Darabos1, Carolyn J Heckman2, Melissa Ozga3, David Kissane3,4, Stephen Rubin5, Norman Rosenblum6.   

Abstract

OBJECTIVE: The aim of this study was to describe emotion episodes during early and late psychotherapy sessions among women newly diagnosed with gynecological cancer and to examine whether the total number of emotion episodes during early and later sessions was associated with baseline psychological distress, dispositional emotion expressivity, and patient-rated therapeutic progress.
METHODS: The study utilized data from an ongoing study examining the efficacy of two psychotherapy interventions, a coping and communication intervention and a supportive counseling intervention, for women diagnosed with gynecological cancer. Emotion episode coding was completed for the first and sixth psychotherapy sessions for each patient randomized to receive psychotherapy (N = 173). Patients completed baseline survey measures of psychological distress and dispositional emotional expressivity and post-session ratings of therapeutic progress.
RESULTS: The average number of emotion episodes was 7.4 in the first session and 5.2 episodes in the sixth session. In both sessions, the majority of emotion episodes contained only negative emotions and focused on a cancer-related topic. A higher number of emotion episodes in the first session was associated with higher psychological distress reported in the baseline survey (p = 0.02). A higher number of emotion episodes in the sixth session was associated with a higher number of emotion episodes in the first session (p < 0.001) and higher patient-rated progress as rated in the sixth session (p = 0.016).
CONCLUSION: The findings highlight the importance of expressed emotions, particularly negative emotions about cancer-related topics, in therapeutic progress during psychotherapy among women diagnosed with gynecological cancer.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; emotion expression; oncology; psychotherapy

Mesh:

Year:  2014        PMID: 25521772      PMCID: PMC4470875          DOI: 10.1002/pon.3737

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  27 in total

1.  Predicting the effect of cognitive therapy for depression: a study of unique and common factors.

Authors:  L G Castonguay; M R Goldfried; S Wiser; P J Raue; A M Hayes
Journal:  J Consult Clin Psychol       Date:  1996-06

2.  Supportive-expressive group therapy: the transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies.

Authors:  David W Kissane; Brenda Grabsch; David M Clarke; George Christie; Diane Clifton; Stan Gold; Christine Hill; Ann Morgan; Fiona McDermott; Graeme C Smith
Journal:  Psychooncology       Date:  2004-11       Impact factor: 3.894

3.  Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy: a preliminary study.

Authors:  Janine Giese-Davis; Sue DiMiceli; Sandra Sephton; David Spiegel
Journal:  Biol Psychol       Date:  2006-06-05       Impact factor: 3.251

4.  Mediators of a coping and communication-enhancing intervention and a supportive counseling intervention among women diagnosed with gynecological cancers.

Authors:  Sharon L Manne; Gary Winkel; Stephen Rubin; Mitchell Edelson; Norman Rosenblum; Cynthia Bergman; Enrique Hernandez; John Carlson; Thomas Rocereto
Journal:  J Consult Clin Psychol       Date:  2008-12

5.  Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes.

Authors:  Katharine Hodgkinson; Phyllis Butow; Anne Fuchs; Glenn E Hunt; Annie Stenlake; Kim M Hobbs; Alison Brand; Gerard Wain
Journal:  Gynecol Oncol       Date:  2006-10-05       Impact factor: 5.482

6.  Not all negative emotions are equal: the role of emotional expression in online support groups for women with breast cancer.

Authors:  Morton A Lieberman; Benjamin A Goldstein
Journal:  Psychooncology       Date:  2006-02       Impact factor: 3.894

7.  Emotional arousal, client perceptual processing, and the working alliance in experiential psychotherapy for depression.

Authors:  Tanya M Missirlian; Shaké G Toukmanian; Serine H Warwar; Leslie S Greenberg
Journal:  J Consult Clin Psychol       Date:  2005-10

Review 8.  Essentials of psychotherapeutic intervention for cancer patients.

Authors:  D Spiegel
Journal:  Support Care Cancer       Date:  1995-07       Impact factor: 3.603

9.  Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

Authors:  Remi A Nout; Hein Putter; Ina M Jürgenliemk-Schulz; Jan J Jobsen; Ludy C H W Lutgens; Elzbieta M van der Steen-Banasik; Jan Willem M Mens; Annerie Slot; Marika C Stenfert Kroese; Bart N F M van Bunningen; Vincent T H B M Smit; Hans W Nijman; Philine P van den Tol; Carien L Creutzberg
Journal:  J Clin Oncol       Date:  2009-06-22       Impact factor: 44.544

10.  Predictors of cancer progression in young adult men and women: avoidance, intrusive thoughts, and psychological symptoms.

Authors:  J E Epping-Jordan; B E Compas; D C Howell
Journal:  Health Psychol       Date:  1994-11       Impact factor: 4.267

View more
  2 in total

1.  Informal caregiver burden and influencing factors in gynaecological oncology patients hospitalized for chemotherapy: a cross-sectional study.

Authors:  Yan Zuo; Bi-Ru Luo; Wen-Tao Peng; Xin-Ru Liu; Ya-Lin He; Jian-Jun Zhang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 2.  Emotional disclosure in palliative care: A scoping review of intervention characteristics and implementation factors.

Authors:  Daisy McInnerney; Nuriye Kupeli; Paddy Stone; Kanthee Anantapong; Justin Chan; Kate Flemming; Nicholas Troop; Bridget Candy
Journal:  Palliat Med       Date:  2021-05-29       Impact factor: 4.762

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.